<DOC>
	<DOCNO>NCT02706860</DOCNO>
	<brief_summary>This study aim compare different perioperative statin regimens prevention post CABG adverse event . This randomize , prospective clinical trial . Ninety four patient schedule elective , isolated on- off- pump CABG randomly assign one 3 treatment group ; 80 mg atorvastatin/day 2 day preoperatively ( N=37 ) , 80 mg atorvastatin/day 5-9 day preoperatively ( N=28 ) 40 mg atorvastatin/day 5-9 day preoperatively ( N=29 ) . The corresponding preoperative dos restart postoperatively ( post-op ) patient able take medication orally continue one month . Cardiac troponin I ( TnI ) , Creatine Kinase ( CK-MB ) C-reactive protein ( CRP ) assay preoperatively post-operatively 8 , 24 , 48 hour , discharge . Marker level compare among three group . The incidence post-operative major adverse cardiac cerebrovascular event ( MACCE ) assess include ; 30-day all-cause mortality , myocardial infarction , atrial fibrillation , ventricular tachycardia/ventricular fibrillation , stroke target-vessel revascularization . The incidence renal hepatic impairment post-operative infection also assess . A Quality life ( QoL ) questionnaire ( EQ-5D-3L ) administer preoperatively 1 month CABG .</brief_summary>
	<brief_title>Efficacy Different Perioperative Statin Regimens Protection Against Post Coronary Artery Bypass Grafting Major Adverse Cardio-cerebral Events</brief_title>
	<detailed_description>This study conduct National Heart Institute ( NHI ) , Cairo , Egypt , period June 2013 February 2015 . It approve ethic committee Faculty Pharmacy , Cairo University , scientific committee NHI . An informed consent obtain study participant approach nature , purpose possible risk study . Preoperative baseline demographic characteristic , preoperative medication , comorbid condition risk factor identify summarize . Design : This randomize , prospective , interventional , open label study . Upon admission NHI , eligible patient randomly assign one 3 treatment group ; group I ( 80 mg atorvastatin/day 2 day preoperatively ) , group II ( 40 mg atorvastatin/day 5-9 day preoperatively ) group III ( 80 mg atorvastatin/day 5-9 day preoperatively ) . Atorvastatin dose reinitiated postoperatively soon patient could take medication orally continue one month operation . The following intra-operative data record patient ; cardiopulmonary bypass time , aortic clamp time , type anesthesia , number graft need blood transfusion . Blood sample draw preoperatively ( baseline ) 8 hour , 24 hour , 48 hour postoperatively hospital discharge . Blood sample spin serum separate , store accord storage condition specify manufacturer , use measure TnI , CK-MB CRP time analysis . Cardiac TnI assay Dimension® TNI method , homogenous sandwich chemiluminescent assay base LOCI® technology , use SIEMENS Dimension® EXL™ , LOCI® Module system . Siemens Healthcare Diagnostics Inc. Newark , USA . CK-MB isoenzyme measure Mass MMB method , one-step enzyme immunoassay base sandwich principle , use SIEMENS Dimension® Heterogeneous Immunoassay Module system . Siemens Healthcare Diagnostics Inc. Newark , USA . CRP measure C-Reactive Protein Extended Range ( RCRP ) method , method base particle enhance turbidimetric immunoassay ( PETIA ) technique , use SIEMENS Dimension® system . Siemens Healthcare Diagnostics Inc. Newark , USA . A-12 lead electrocardiogram ( ECG ) perform pre-operatively , intensive care unit ( ICU ) upon patient transfer ward . The appearance new Q-waves indicate myocardial infarction ( MI ) incidence arrhythmia report . Echocardiography perform pre-operatively post-operatively ICU discharge detect new wall movement abnormality well . Measured end point follow : 1 ) Incidence post-operative major adverse cardiac cerebrovascular event ( MACCE ) include ; 30-days all-cause mortality , MI , AF , ventricular tachycardia ventricular fibrillation , debilitate stroke transient ischemic attack ( TIA ) target-vessel revascularization ; 2 ) renal impairment ; 3 ) hepatic impairment ; 4 ) postoperative infection ; 5 ) persistent blood glucose abnormality ; 6 ) length ICU hospital stay , health-related quality-of-life ( HRQoL ) . HRQoL assess use Euro Quality Life 5-Dimensional Classification ( EQ-5D-3L ) 19 baseline ( preoperatively ) patient admit NHI one month postoperatively follow-up visit contact patient via phone call .</detailed_description>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<criteria>Ischemic Heart Disease patient refer elective isolated pump CABG Adult patient normal preoperative hemoglobin , hematocrit , albumin , cardiac marker ; Cardiac troponin I ( TnI ) Creatine KinaseMB ( CKMB ) level . Serum creatinine &lt; 2 mg/dl aspartate aminotransferase ( AST ) alanine aminotransferase ( ALT ) &lt; 3 time upper normal limit ( UNL ) . Recent history stroke , myocardial infarction ( MI ) , atrial fibrillation ( AF ) type arrhythmia . Any malignancy , inflammatory muscle disease include study . Hypersensitivity statins medication know interact statin .</criteria>
	<gender>All</gender>
	<minimum_age>42 Years</minimum_age>
	<maximum_age>71 Years</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>